NADAC acquisition cost data for MERZEE 1 MG-20 MCG CAPSULE. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 43386037132 | $0.9406 | 2022-12-21 | Rx |
| 71225013001 | $0.9406 | 2022-12-21 | Rx |
| 43386037132 | $0.9406 | 2022-12-21 | Rx |
Generic: Norethindrone-E.Estradiol-Iron | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A |
| 2023 | $3.4K | 28 | N/A | $3.35 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| South Carolina | $1.6K | 12 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.